{"id":225,"date":"2018-05-23T19:19:55","date_gmt":"2018-05-23T19:19:55","guid":{"rendered":"http:\/\/tagliente.nl\/?page_id=225"},"modified":"2023-09-29T19:34:18","modified_gmt":"2023-09-29T19:34:18","slug":"farmacie-geneesmiddelen","status":"publish","type":"page","link":"https:\/\/tagliente.nl\/?page_id=225","title":{"rendered":"Pharmaceuticals"},"content":{"rendered":"\n

In response to rising health care costs, ageing population with increased multimorbidity,
and avoidable hospitalizations due to adverse drug reactions the role of community pharmacists is becoming increasingly important to counsel patients, ensure a safer use of medicines, improve clinical outcomes, integrate with other health providers, and increase health education among patients. Many countries face the challenge to better reward community pharmacists for their daily work. What alternative payment methods can be thought of to fund quality-linked interventions by pharmacists?
Regulation, reimbursement and pricing in the pharmaceutical industry are of special
interest to us. We offer the pharmaceutical industry a better understanding of the Dutch institutional framework, the procedures for drugs market access and reimbursement, the negotiations with hospitals, health insurers, and the Dutch Government when the drug is admitted in the lock system.<\/p>\n\n\n\n

Achieving Excellence in Pharmaceutical Care\u2014Different Payment Models<\/strong><\/h3>\n\n\n\n

On 1 October 2020, Ilaria was invited as a speaker to the Special Interest Group (SIG) International<\/a> of the Royal Dutch Pharmacists Association (Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie, KNMP).<\/p>\n\n\n\n

In response to rising health care costs, ageing population with increased multimorbidity, and avoidable hospitalizations due to adverse drug reactions (ADRs) the role of community pharmacists is becoming increasingly important to counsel patients, ensure a safer use of medicines, improve clinical outcomes, integrate with other health providers, and increase health education among patients.<\/p>\n\n\n\n

Many countries face the challenge to better reward community pharmacists for their daily work. In the Netherlands, community pharmacists are remunerated on a fee-for-service basis that funds the number of prescriptions dispensed but does not reward quality.<\/p>\n\n\n\n

Alternative payment methods that fund quality-linked interventions by pharmacists\u2014think of patient counseling, improved medicines adherence, the provision of medicines in dose administration aids, etc.\u2014are not yet widespread with few exceptions in North Carolina (USA) and Australia.<\/p>\n\n\n\n

Ilaria\u2019s presentation sheds light on alternative payment methods in community pharmacy such as pay-for-performance (P4P) that may reward structure, process, and outcomes with the ultimate goal to improve quality. For more information, please contact info@tagliente.nl<\/a><\/p>\n\n\n\n

Market Access and Pricing <\/h3>\n\n\n
\n
\"\"<\/a><\/figure>\n<\/div>\n\n\n

Regulation, reimbursement and pricing in the pharmaceutical  industry are of special interest for Tagliente.      <\/p>\n\n\n\n

We can offer the pharmaceutical industry a better understanding of the Dutch institutional framework,  the procedures for market access and reimbursement, the negotiations with hospitals, health insurers but also with the Dutch government when the drug is admitted in the lock system.  We can help the industry sharpen their strategy. The Lock (sluis) for new medicines<\/a><\/p>\n\n\n

\n
\"\"<\/figure>\n<\/div>\n\n\n


<\/a><\/p>\n\n\n\n

At the same time we do believe that the current regulation is not working that well but alternatives are difficult to implement.  We can offer all parties concerned with the development of new pricing systems to promote innovation but also competitive pricing.<\/p>\n","protected":false},"excerpt":{"rendered":"

In response to rising health care costs, ageing population with increased multimorbidity,and avoidable hospitalizations due to adverse drug reactions the role of community pharmacists is becoming increasingly important to counsel patients, ensure a safer use of medicines, improve clinical outcomes, integrate with other health providers, and increase health education among patients. Many countries face the … Lees verder Pharmaceuticals<\/span> →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"jetpack_post_was_ever_published":false,"footnotes":""},"class_list":["post-225","page","type-page","status-publish","hentry"],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/P6OSc1-3D","jetpack-related-posts":[{"id":284,"url":"https:\/\/tagliente.nl\/?page_id=284","url_meta":{"origin":225,"position":0},"title":"Presentations","date":"19\/07\/2020","format":false,"excerpt":"Achieving Excellence in Pharmaceutical Care\u2014Different Payment Models On 1 October 2020, Ilaria was invited as a speaker to the Special Interest Group (SIG) International of the Royal Dutch Pharmacists Association (Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie, KNMP). In response to rising health care costs, ageing population with increased multimorbidity,\u2026","rel":"","context":"Soortgelijk bericht","img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":331,"url":"https:\/\/tagliente.nl\/?page_id=331","url_meta":{"origin":225,"position":1},"title":"Speeches & Publications","date":"05\/01\/2022","format":false,"excerpt":"Keynote Speeches Long-term care \u2014 World Bank In September 2023, Ilaria was the main speaker at an online webinar on long-term care in the Netherlands, presented to esteemed representatives from the Polish Government (Ministry of Health, Ministry of Labor and Social Policy, Ministry of Development Funds and Regional Policy), the\u2026","rel":"","context":"Soortgelijk bericht","img":{"alt_text":"","src":"https:\/\/i0.wp.com\/tagliente.nl\/wp-content\/uploads\/2023\/10\/Image-presentation-MOSCA.jpg?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":10,"url":"https:\/\/tagliente.nl\/?page_id=10","url_meta":{"origin":225,"position":2},"title":"Expertise","date":"06\/10\/2015","format":false,"excerpt":"International We advise governments and donors in different countries on the development of health systems. This advise could be an assessment of the health system but also on more strategic issues like transition to a more competitive environment, efficiency in het system with quality indicators, health financing and funding. International\u2026","rel":"","context":"Soortgelijk bericht","img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":648,"url":"https:\/\/tagliente.nl\/?page_id=648","url_meta":{"origin":225,"position":3},"title":"Health Policy & Governance","date":"28\/08\/2023","format":false,"excerpt":"Strengthening Health Systems We focus on improving the capacity and performance of healthcare systems to deliver accessible, high-quality, and equitable services. Our goal is to build resilient and efficient systems that can provide essential care to all, particularly in resource-constrained settings. We ensure that health systems are responsive to current\u2026","rel":"","context":"Soortgelijk bericht","img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":46,"url":"https:\/\/tagliente.nl\/?page_id=46","url_meta":{"origin":225,"position":4},"title":"Portfolio","date":"07\/10\/2015","format":false,"excerpt":"Tagliente offers an extensive portfolio of international and national consulting and interim assignments, complemented by thought leadership through speeches and publications. Our consultancy work is strongly international, supporting organisations such as CEPI, the World Bank, and WHO, as well as national agencies operating globally, including the Swiss Agency for Development\u2026","rel":"","context":"Soortgelijk bericht","img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":628,"url":"https:\/\/tagliente.nl\/?page_id=628","url_meta":{"origin":225,"position":5},"title":"Public Health & Care delivery","date":"23\/08\/2023","format":false,"excerpt":"Infectious Disease and Vaccine Preparedness We examine health systems to identify weaknesses in antimicrobial stewardship, diagnostics, and surveillance. Tagliente designs system-level interventions to improve the appropriate use of antimicrobials and strengthen overall infectious disease management. We also provide strategic advice on vaccine preparedness, manufacturing, and equitable distribution, helping countries ensure\u2026","rel":"","context":"Soortgelijk bericht","img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"_links":{"self":[{"href":"https:\/\/tagliente.nl\/index.php?rest_route=\/wp\/v2\/pages\/225","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tagliente.nl\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/tagliente.nl\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/tagliente.nl\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/tagliente.nl\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=225"}],"version-history":[{"count":10,"href":"https:\/\/tagliente.nl\/index.php?rest_route=\/wp\/v2\/pages\/225\/revisions"}],"predecessor-version":[{"id":753,"href":"https:\/\/tagliente.nl\/index.php?rest_route=\/wp\/v2\/pages\/225\/revisions\/753"}],"wp:attachment":[{"href":"https:\/\/tagliente.nl\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=225"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}